Average Co-Inventor Count = 5.18
ph-index = 3
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Glaxosmithkline Biologicals Sa (12 from 531 patents)
2. National Institutes of Health, a Component of the US Dept. of Health & Human Services (2 from 3,435 patents)
12 patents:
1. 11957749 - Hepatitis B immunization regimen and compositions
2. 11795478 - Adenovirus polynucleotides and polypeptides
3. 11702674 - Simian adenovirus vectors comprising the ChAd-157 fiber protein
4. 11414679 - Adenovirus polynucleotides and polypeptides
5. 11268108 - Replication competent adenoviral vectors
6. 11254710 - Adenovirus polynucleotides and polypeptides
7. 11254711 - Adenovirus polynucleotides and polypeptides
8. 11214599 - Recombinant simian adenoviral vectors encoding a heterologous fiber protein and uses thereof
9. 10584355 - Chimpanzee adenoviral vector-based filovirus vaccines
10. 10544192 - Chimpanzee clade E adenovirus nucleic acid-and amino acid-sequences, vectors containing same, and uses thereof
11. 9718863 - Simian adenovirus nucleic acid- and amino acid-sequences, vectors containing same, and uses thereof
12. 9526777 - Methods for the induction of ebola virus-specific immune responses comprising administering a replication-defective chimpanzee adenovirus vector expressing the ebola virus glycoprotein